外汇新闻

Pfizer Q1 Results Top Estimates; Reaffirms FY23 Outlook

Pfizer Q1 Results Top Estimates; Reaffirms FY23 Outlook

Drug major Pfizer Inc. reported a profit for the first quarter that decreased 30 percent from last year, hurt by a 29 percent revenue drop amid a decline for COVID-19 products and an unfavorable impact of foreign exchange. Both adjusted earnings and quarterly revenues topped analysts' expectations. The company also reaffirmed its adjusted earnings and revenue guidance for the full-year 2023.
RTTNews | 827天前
Eurozone Inflation Rises As Expected In April

Eurozone Inflation Rises As Expected In April

Eurozone inflation rose slightly in April on food and non-energy industrial goods prices, while core inflation slowed marginally, flash data from Eurostat showed on Tuesday. The harmonized inflation of consumer prices posted an annual growth of 7.0 percent in April, following a 6.9 percent rise in March. The rate came in line with economists' expectations.
RTTNews | 827天前
Zimmer Biomet Boosts FY23 Outlook - Update

Zimmer Biomet Boosts FY23 Outlook - Update

While reporting financial results for the first quarter on Tuesday, musculoskeletal healthcare firm Zimmer Biomet Holdings Inc. (ZBH) raised its adjusted earnings and revenue growth outlook for the full-year 2023.
RTTNews | 827天前
BP Posts RC Profit In Q1, Underlying RC Profit Down; Stock Dips

BP Posts RC Profit In Q1, Underlying RC Profit Down; Stock Dips

British energy major BP Plc reported Tuesday a replacement cost profit in its first quarter, compared to last year's hefty loss, while underlying replacement cost profit was lower as last year was benefited by surge in fuel prices following Russia's invasion of Ukraine. The company also announced a further $17.5 billion share buyback. BP shares were losing around 5 percent in the morning trading
RTTNews | 827天前
more news
Australia Central Bank Hikes Rate Unexpectedly Despite Slowing Inflation

Australia Central Bank Hikes Rate Unexpectedly Despite Slowing Inflation

Despite an easing in inflation, the Reserve Bank of Australia unexpectedly raised its benchmark interest rate by a quarter-point and signaled more hikes to bring inflation back to the target in a reasonable timeframe. The RBA Board decided to hike the cash rate target by 25 basis points to 3.85 percent. This was the highest rate since early 2012.
RTTNews | 827天前
FDA Approves First Drug For Anemia In Cats With CKD

FDA Approves First Drug For Anemia In Cats With CKD

The U.S. Food and Drug Administration conditionally approved Elanco US Inc.'s Varenzin-CA1 (molidustat oral suspension) for treating anemia in cats with chronic kidney disease or CKD. It is the first drug for the control of nonregenerative anemia associated with CKD in cats. Varenzin-CA1 works by helping to increase production of erythropoietin in the kidney, which in turn stimulates the bone mar
RTTNews | 827天前

Stay up to date!

Add 新闻 to your browser

Extension Picture